Trial Profile
Proof-of-pharmacology clinical trial on a vaccine that elicits a protective humoral immune response against oxidized low density lipoprotein oxidized low density lipoprotein
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2017
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions; Therapeutic Use
- 23 Sep 2016 New trial record